223 related articles for article (PubMed ID: 8177121)
21. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].
Thix J
Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823
[TBL] [Abstract][Full Text] [Related]
22. [Prenatal screening for Down's syndrome].
Qin Q; Christiansen M; Norgaard-Pedersen B
Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):694-7. PubMed ID: 9639772
[No Abstract] [Full Text] [Related]
23. Screening for Down's syndrome. Conclusions do not reflect reality.
Reynolds T
BMJ; 2002 Jan; 324(7329):111. PubMed ID: 11808522
[No Abstract] [Full Text] [Related]
24. Integrated screening for Down's syndrome.
Chen FM
J Fam Pract; 1999 Nov; 48(11):846-7. PubMed ID: 10907617
[No Abstract] [Full Text] [Related]
25. Prenatal screening for open neural tube defects and Down syndrome: three decades of progress.
Wald NJ
Prenat Diagn; 2010 Jul; 30(7):619-21. PubMed ID: 20572104
[No Abstract] [Full Text] [Related]
26. Amniocentesis in the second trimester.
Med Lett Drugs Ther; 1978 Oct; 20(21):93-4. PubMed ID: 151773
[No Abstract] [Full Text] [Related]
27. Ultrasonographic and biochemical markers in prenatal detection of Down's syndrome and neural tube defects.
Calda P
Funct Dev Morphol; 1992; 2(2):135-7. PubMed ID: 1450459
[No Abstract] [Full Text] [Related]
28. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
29. [Clinical use of 7 methods of prenatal diagnosis of neural tube defects].
Li SR
Zhonghua Fu Chan Ke Za Zhi; 1988 Nov; 23(6):341-4, 387. PubMed ID: 3248425
[No Abstract] [Full Text] [Related]
30. [Screening by maternal serum markers for Down's syndrome].
Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
[TBL] [Abstract][Full Text] [Related]
31. Screening for Down's syndrome. Modelling does not predict reality accurately.
Howe D
BMJ; 2002 Jan; 324(7329):111-2. PubMed ID: 11808523
[No Abstract] [Full Text] [Related]
32. Estimating risk of Down's syndrome.
BMJ; 1991 Jun; 302(6791):1536-7. PubMed ID: 1830232
[No Abstract] [Full Text] [Related]
33. Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies.
Morris JK; Wald NJ
J Med Screen; 2007; 14(1):5-7. PubMed ID: 17362564
[TBL] [Abstract][Full Text] [Related]
34. Immunochemical determination of amniotic fluid acetylcholinesterase in the antenatal diagnosis of open neural tube defects.
Loft AG
Dan Med Bull; 1995 Feb; 42(1):54-70. PubMed ID: 7729170
[TBL] [Abstract][Full Text] [Related]
35. Maternal serum screening for neural tube defects and Down's syndrome--the NSW perspective.
Field B; Robertson R; Saunders DM
Med J Aust; 1991 Nov; 155(10):728. PubMed ID: 1834925
[No Abstract] [Full Text] [Related]
36. Maternal serum screening.
Lofsky S
CMAJ; 1999 Apr; 160(8):1125-6. PubMed ID: 10234332
[No Abstract] [Full Text] [Related]
37. Serum screening for Down's syndrome. Private patients may receive less counselling.
Boyd PA
BMJ; 1994 Nov; 309(6965):1372. PubMed ID: 7726955
[No Abstract] [Full Text] [Related]
38. [Arguments for offering triple test serum screening for Down's syndrome to all pregnant women].
van der Maas PJ; Dondorp WJ
Ned Tijdschr Geneeskd; 2002 Mar; 146(11):501-3. PubMed ID: 11925798
[TBL] [Abstract][Full Text] [Related]
39. 46,XY,i(21q) identified by maternal serum screening.
Meyers CM; Ghori S; Roberson AE; Blitzer MG; Cohen MM
Md Med J; 1997 Feb; 46(2):88-9. PubMed ID: 9029908
[TBL] [Abstract][Full Text] [Related]
40. Women as moral pioneers? Experiences of first trimester antenatal screening.
Williams C; Sandall J; Lewando-Hundt G; Heyman B; Spencer K; Grellier R
Soc Sci Med; 2005 Nov; 61(9):1983-92. PubMed ID: 15899542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
